Friday, May 6, 2022 | 10 – 4 PM ET
Live Virtual Event
Background
Lyme disease is a worldwide epidemic, with over 476,000 new cases each year in the US. Treating all manifestations of Lyme disease can be challenging. Cases may be misdiagnosed and treatments delayed and/or inadequate. An estimated 14-30% of individuals suffer from functionally impairing Lyme disease associated persistent symptoms.
Clinical and Research Advances in Lyme Disease Symposium
This one-day symposium provides the latest clinical and research information on Lyme disease and tickborne diseases and will help health practitioners better understand and treat acute Lyme disease, Lyme arthritis, Lyme carditis, and “long haul” Lyme disease complexities.
Who should attend?
The Lyme Disease Symposium is available to healthcare practitioners, including general practitioners, family practice, internal medicine, infectious diseases, rheumatology, orthopedic surgery, neuropsychology, physician assistants, nurse practitioners, nurses and other healthcare providers.
AGENDA AND FACULTY
Agenda
Clinical and Research Advances in Lyme Disease Symposium
| Time | Topic |
|---|---|
| 10:00am | Welcome & Overview John Aucott, MD |
| 10:15am-10:45am | Ecology, Tick Epidemiology, and Emerging Pathogens Mark Soloski, PhD |
| 10:45am-11:15am | Lyme Disease Epidemiology Alison Rebman, MPH |
| 11:15am-11:45am | Signs, Symptoms and Diagnostic Testing for Acute Lyme Disease John Aucott, MD |
| 11:45am-12:15pm | Lyme Carditis and Other Lyme Disease Associated Heart Complications Adrian Baranchuk, MD |
| 12:15pm-12:45pm | Lunch |
| 12:45pm-1:15pm | Lessons from ME/CFS that can inform Lyme disease as well as Long COVID Peter Rowe, MD |
| 1:15pm-1:45pm | Persistent Symptoms in Lyme Disease John Aucott, MD |
| 1:45pm-2:00pm | Infection Associated Chronic Illnesses Q&A John Aucott, MD Peter Rowe, MD |
| 2:00-2:30pm | Lyme Arthritis John Miller, MD |
| 2:30pm-2:45pm | Break |
| 2:45pm-3:15pm | Lyme Disease Cognitive and Behavioral Symptom Management Pegah Touradji, PhD |
| 3:15pm-3:45pm | Psilocybin Clinical Trials: Potential in Post Treatment Lyme Disease Albert Garcia-Romeu, PhD |
| 3:45pm-4:00pm | Q&A and Concluding Remarks John Aucott, MD |
Faculty
John Aucott, MD
Associate Professor of Medicine, Johns Hopkins University School of Medicine
Director, Johns Hopkins Lyme Disease Research Center
Adrian Baranchuk, MD, FACC, FRCPC, FCCS, FSIAC
Professor of Medicine, Queen’s University, Ontario, Canada
Editor-in-Chief, Journal of Electrocardiology; Editor-in-Chief, JACC in Spanish
Vice President, International Society of Electrocardiology (ISHNE)
President Elect, Interamerican Society of Cardiology (SIAC)
Albert Garcia-Romeu, PhD
Assistant Professor of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine
John Miller, MD
Assistant Professor of Medicine, Johns Hopkins University School of Medicine
Lyme Arthritis Program, Johns Hopkins Lyme Disease Research Center
Alison Rebman, MPH
Instructor in Medicine, Johns Hopkins University School of Medicine
Co-Director for Clinical and Epidemiological Research, Johns Hopkins Lyme Disease Research Center
Peter Rowe, MD
Professor of Pediatrics, Johns Hopkins University School of Medicine
Director, Children’s Center Chronic Fatigue Clinic
Mark J. Soloski, PhD
Professor of Medicine, Johns Hopkins University School of Medicine
Senior Advisor, Johns Hopkins Lyme Disease Research Center
Pegah Touradji, PhD
Assistant Professor of Physical Medicine and Rehabilitation, Division of Rehabilitation Psychology and Neuropsychology, Johns Hopkins University School of Medicine
Lyme Disease Rehabilitation Neuropsychology Program, Johns Hopkins Lyme Disease Research Center
